Equities

Pharmaust Ltd

Pharmaust Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.18
  • Today's Change0.01 / 5.88%
  • Shares traded210.87k
  • 1 Year change+130.77%
  • Beta1.6495
Data delayed at least 20 minutes, as of Sep 20 2024 07:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of AUD
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
ASSETS
Cash And Short Term Investments9.712.712.42
Total Receivables, Net0.020.150.19
Total Inventory001.04
Prepaid expenses------
Other current assets, total1.390.170.09
Total current assets113.023.73
Property, plant & equipment, net00.003.24
Goodwill, net------
Intangibles, net03.113.11
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets116.1310
LIABILITIES
Accounts payable0.830.930.60
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases00.160.35
Other current liabilities, total0.070.260.21
Total current liabilities0.901.351.17
Total long term debt00.891.04
Total debt01.051.39
Deferred income tax------
Minority interest------
Other liabilities, total0.000.000.03
Total liabilities0.902.242.23
SHAREHOLDERS EQUITY
Common stock705855
Additional paid-in capital------
Retained earnings (accumulated deficit)(60)(54)(47)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity103.897.84
Total liabilities & shareholders' equity116.1310
Total common shares outstanding445347317
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.